Eton Pharmaceuticals
Highly Engaged Employees
Manufacturing · Illinois, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
21925 W Field Pkwy Ste 235, Deer Park, I...Phone Number
(847) 787-7361Website
www.etonpharma.comRevenue
$105.6 MillionStock Symbol
ETONIndustry
About Eton Pharmaceuticals
Eton Pharmaceuticals Inc, a specialty pharmaceutical company, focuses on developing, acquiring, and commercializing pharmaceutical products for rare diseases. The company offers ALKINDI SPRINKLE, a replacement therapy for adrenocortical insufficiency in children, Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate Synthase deficiency; Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of tyrosinemia type 1. It also provides Zeneo hydrocortisone autoinjector for the treatment of adrenal crisis.Explore more
SIC Code 28,283NAICS Code 32,325Ticker NASDAQ: ETONShow moreEton Pharmaceuticals Org Chart
Compare Similar Companies to Eton Pharmaceuticals
Compare insights from companies similar to Eton Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
<$5M
11-50
Private
-
2005
Li QiaoSenior VP, Program Management Regulatory Affairs & Chief Operating Officer
Eton Pharmaceuticals Tech Stack
A closer look at the technologies used by Eton Pharmaceuticals
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Eton Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Eton Pharmaceuticals Inc, a specialty pharmaceutical company, focuses on developing, acquiring, and commercializing pharmaceutical products for rare diseases. The company offers ALKINDI SPRINKLE, a replacement therapy for adrenocortical insufficiency in children, Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylgl... Read More

